SEC Comment Letter 0000000000-26-002754 to Adicet Bio, Inc. (ACET)
Adicet Bio, Inc.
Date: March 18, 2026 · CIK: 0001720580 · Accession: 0000000000-26-002754
AI Filing Summary & Sentiment
File numbers found in text: 333-294265
Letter
March 18, 2026 Chen Schor Chief Executive Officer Adicet Bio, Inc. 131 Dartmouth Street, 3rd Floor Boston, MA 02116 Re:Adicet Bio, Inc. Registration Statement on Form S-3 Filed March 12, 2026 File No. 333-294265 Dear Chen Schor: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Gabriela Morales-Rivera, Esq.
Show Raw Text
March 18, 2026
Chen Schor
Chief Executive Officer
Adicet Bio, Inc.
131 Dartmouth Street, 3rd Floor
Boston, MA 02116
Re:Adicet Bio, Inc.
Registration Statement on Form S-3
Filed March 12, 2026
File No. 333-294265
Dear Chen Schor:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Gabriela Morales-Rivera, Esq.